1. Stacy Lawrence is Senior Writer, BioCentury

Introduction

The divide between compensation for R&D staff in industry and academia continues to widen. Median average salary in a private organization is now $30,000 more than in academia. Despite the economic downturn, life sciences execs as a whole are targeting a 9% average increase in their cash compensation in 2008; CEOs are even more aggressive, aiming for an average 12% rise to $400,000. Top execs based in New England make the most on average; those in the Midwest receive 20–33% less.

Median salaries in industry and academia

Life sciences executive perks

Biotech employees, revenue R&D

Life sciences executives' cash compensation

Employment at public biotech companies by region

Cash compensation by US region

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NPG Journals

by Subject Area

• Chemistry

  • Chemistry
  • Drug discovery
  • Biotechnology
  • Materials
  • Methods & Protocols

• Clinical Practice & Research

  • Cancer
  • Cardiovascular medicine
  • Dentistry
  • Endocrinology
  • Gastroenterology & Hepatology
  • Methods & Protocols
  • Pathology & Pathobiology
  • Urology

• Earth & Environment

  • Earth sciences
  • Evolution & Ecology

• Life sciences

  • Biotechnology
  • Cancer
  • Development
  • Drug discovery
  • Evolution & Ecology
  • Genetics
  • Immunology
  • Medical research
  • Methods & Protocols
  • Microbiology
  • Molecular cell biology
  • Neuroscience
  • Pharmacology
  • Systems biology

• Physical sciences

  • Physics
  • Materials

by A - Z Index